Phenotypic patterns of metabolic dysfunction‐associated steatotic liver disease in type 2 diabetes: The impact of insulin

Two new MASLD-T2D phenotypes have been identified, HepGluc[+] and HepGluc[-], according to IGLU patterns, with HepGluc[+] being more deleterious due to higher systemic IR, steatosis and inflammation. Phenotypes can be identified using a new function, the MASLD-T2D score.

Authors

Institutions

Publication Details

Journal
European Journal of Clinical Investigation
Published
2025-04-18
DOI
https://doi.org/10.1111/eci.70050
Citations
4
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
5.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phenotypic patterns of metabolic dysfunction‐associated steatotic liver disease in type 2 diabetes: The impact of insulin

Albert Roque, H Cuellar, Jaume Baguñà, Miguel Á. González Ballester et al.
4 citations
European Journal of Clinical Investigation
Liver Disease Diagnosis and Treatment
5.42
article

Phenotypic patterns of metabolic dysfunction‐associated steatotic liver disease in type 2 diabetes: The impact of insulin

Albert Roque, H Cuellar, Jaume Baguñà, Miguel Á. González Ballester, Clara Ramírez, Queralt Martín‐Saladich, José Raúl Herance, Juan M. Pericàs, Santiago Aguadé‐Bruix, Andreea Ciudin, Rafael Simó, María Nazarena Pizzi, Nuria Roson‐Gradaille
article en
4 citations

Abstract

Two new MASLD-T2D phenotypes have been identified, HepGluc[+] and HepGluc[-], according to IGLU patterns, with HepGluc[+] being more deleterious due to higher systemic IR, steatosis and inflammation. Phenotypes can be identified using a new function, the MASLD-T2D score.

European Journal of Clinical InvestigationVol. 55(9)
Institució Catalana de Recerca i Estudis Avançats (ES), Universitat Pompeu Fabra (ES), Instituto de Salud Carlos III (ES), Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES), Vall d'Hebron Institut de Recerca (ES), Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
Fundació Institut de Recerca Hospital Universitari Vall d’Hebron, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III
Openalex Percentile: Top 5%
Liver Disease Diagnosis and Treatment
5.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.